Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

762
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
762

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenosine as a metabolic checkpoint in CD8+ T cell dysfunction.

Trends in immunology·2026
Same author

Mechanistic analysis of MLKL-driven cell survival.

Cell death discovery·2026
Same author

ACSS2 Suppresses Ferroptosis to Drive Breast Cancer Brain Metastasis.

Cancer research·2026
Same author

Sugar Storm: O-GlcNAc signaling amid the clouds of cancer complexity.

Glycobiology·2026
Same author

New job for an old tool: PI3Kβ phosphorylates OGT to regulate acetyl-CoA in glioblastoma.

Trends in cell biology·2025
Same author

GATAD2B O-GlcNAcylation Regulates Breast Cancer Stem-like Potential and Drug Resistance.

Cells·2025

Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

1.5K

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy.

Sergey V Karakashev1, Mauricio J Reginato1

  • 1Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.

Cancer Management and Research
|August 29, 2015
PubMed
Summary

Hypoxic tumors resist cancer therapies, impacting patient outcomes. Understanding hypoxia-inducible factor 1 pathways is key to overcoming this resistance.

Keywords:
HIF-1apoptosiscancerchemoresistancesignaling

More Related Videos

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

4.1K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

13.0K

Related Experiment Videos

Last Updated: Apr 4, 2026

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

1.5K
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

4.1K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

13.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor hypoxia is linked to poor clinical outcomes in various cancers.
  • Hypoxic cancer cells exhibit resistance to radiation, chemotherapy, and targeted treatments.
  • Hypoxia-inducible factor 1 (HIF-1) is a critical regulator of cellular responses to low oxygen environments.

Purpose of the Study:

  • To review pathways regulated by hypoxia and HIF-1 in cancer cells.
  • To discuss recent advancements in overcoming hypoxia-driven therapeutic resistance.

Main Methods:

  • Literature review of studies on hypoxia and HIF-1 in cancer.
  • Analysis of gene expression and cellular processes regulated by hypoxia.
  • Synthesis of current strategies to counteract hypoxia-mediated resistance.

Main Results:

  • HIF-1 regulates key cancer processes: cell survival, proliferation, metabolism, invasion, and angiogenesis.
  • Hypoxia contributes to treatment failure through multiple resistance mechanisms.
  • Emerging strategies aim to target HIF-1 or its downstream effectors.

Conclusions:

  • Targeting hypoxia and HIF-1 pathways offers a promising approach to improve cancer treatment efficacy.
  • Further research into hypoxia-mediated resistance mechanisms is crucial for developing novel therapies.
  • Overcoming tumor hypoxia is essential for enhancing patient response to anticancer treatments.